skip to Main Content

IBT’s reagent line covers a range of viruses. Product types include antisera, and purified polyclonal antibodies against these viruses.

Specific targets covered include Crimean-Congo Hemorrhagic Fever Virus (CCHFV); Japanese Encephalitis Virus (JEV); Junin and Lassa Viruses; Rift Valley Fever Virus (RVFV); Vaccinia; etc.

If you have any questions or would like to inquire about discounts for bulk purchases, please contact us.

NotesProduct NameTargetCat #SizeDatasheetPriceBuy
Nipah virus Attachment G proteinNipah virus0580-001100 ug$460.00
Rabbit anti-CCHFV Gc pAbCrimean-Congo Hemorrhagic Fever Virus04-0012100ug$450.00
Rabbit anti-CCHFV N protein pAbCrimean-Congo Hemorrhagic Fever Virus04-0011100 ug$450.00
Rabbit anti-Japanese Encephalitis (JEV) antiserumJapanese Encephalitis Virus01-0007250 uL$354.00
Rabbit anti-Junin antiserumJunin Virus01-0006250 uL$396.00
Rabbit anti-Junin pAbJunin Virus04-0006500 ug$240.00
Rabbit anti-LASV GP pAbLassa Virus0307-001100 ug$420.00
Rabbit anti-LASV Z pAbLassa Virus0307-002100 ug$420.00
Out of StockRabbit anti-Rift Valley Fever (RVFV) antiserumRabbit anti-Rift Valley Fever (RVFV) antiserum01-0001250 uL$396.00
Out of StockRabbit anti-Rift Valley Fever (RVFV) pAbRift Valley Fever Virus04-0001500 ug$240.00
Rabbit anti-Vaccinia antiserumVaccinia Virus01-0003250 uL$396.00
Rabbit anti-Zika GP pAbZika virus0308-001100 ug$425.00
Rabbit anti-Zika NS1 pAbZika Virus0308-002100 ug$425.00
Recombinant Lassa Virus Z ProteinLassa Virus0508-001100 ug$435.00
Recombinant Zika Ev2-dimer (S2)Zika Virus0556-002100 ug$435.00
Recombinant Zika Ev2-monomer (S2)Zika Virus0556-001100 ug$435.00
Recombinant Zika Ns2B-Ns3 (S2)Zika Virus0555-001100 ug$435.00
West Nile Virus-NS1 (S2)West Nile Viurs0557-001100 ug$435.00
Back To Top
Fig. 1 Survival after challenge with INFV H1N1 A/Pert/261/2009 (Tamiflu-resistant strain). Inoculum 1xLD90=1.0E+05 PFU/mouse
Survival after challenge with INFV H1N1 A/Pert/261/2009 (Tamiflu-resistant strain) 1.0E+05 PFU/mouse
Survival and weight change in BALB/c mice challenged with INFV A/ Texas/36/91 (H1N1) and treated with antiviral Osletamivir Phosphate (Tamiflu)
Lung viral load and Survival (30 % weight loss cut-off) in BALB/c mice challenged with INFV H3N2 A/HK/1/68.